Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Targeting of the purine biosynthesis host cell pathway enhances the activity of tenofovir against sensitive and drug-resistant HIV-1.

Heredia A, Davis CE, Reitz MS, Le NM, Wainberg MA, Foulke JS, Wang LX, Redfield RR.

J Infect Dis. 2013 Dec 15;208(12):2085-94. doi: 10.1093/infdis/jit395. Epub 2013 Aug 6.

2.

Human mesenchymal stem cells inhibit endothelial proliferation and angiogenesis via cell-cell contact through modulation of the VE-Cadherin/β-catenin signaling pathway.

Menge T, Gerber M, Wataha K, Reid W, Guha S, Cox CS Jr, Dash P, Reitz MS Jr, Khakoo AY, Pati S.

Stem Cells Dev. 2013 Jan 1;22(1):148-57. doi: 10.1089/scd.2012.0165. Epub 2012 Jun 26.

3.

Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling.

Pati S, Khakoo AY, Zhao J, Jimenez F, Gerber MH, Harting M, Redell JB, Grill R, Matsuo Y, Guha S, Cox CS, Reitz MS, Holcomb JB, Dash PK.

Stem Cells Dev. 2011 Jan;20(1):89-101. doi: 10.1089/scd.2010.0013. Epub 2010 Oct 18.

4.

Suppression of MIP-1beta transcription in human T cells is regulated by inducible cAMP early repressor (ICER).

Barabitskaja O, Foulke JS Jr, Pati S, Bodor J, Reitz MS Jr.

J Leukoc Biol. 2006 Feb;79(2):378-87.

PMID:
16443828
5.

A biochemical analysis of topoisomerase II alpha and beta kinase activity found in HIV-1 infected cells and virus.

Kondapi AK, Padmaja G, Satyanarayana N, Mukhopadyaya R, Reitz MS.

Arch Biochem Biophys. 2005 Sep 1;441(1):41-55.

PMID:
16091284
6.

An in vivo replication-important function in the second coding exon of Tat is constrained against mutation despite cytotoxic T lymphocyte selection.

Smith SM, Pentlicky S, Klase Z, Singh M, Neuveut C, Lu CY, Reitz MS Jr, Yarchoan R, Marx PA, Jeang KT.

J Biol Chem. 2003 Nov 7;278(45):44816-25. Epub 2003 Aug 27.

7.

A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice.

Agwale SM, Shata MT, Reitz MS Jr, Kalyanaraman VS, Gallo RC, Popovic M, Hone DM.

Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):10037-41. Epub 2002 Jul 2.

8.

Antitumorigenic effects of HIV protease inhibitor ritonavir: inhibition of Kaposi sarcoma.

Pati S, Pelser CB, Dufraine J, Bryant JL, Reitz MS Jr, Weichold FF.

Blood. 2002 May 15;99(10):3771-9.

9.

Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector.

Shata MT, Reitz MS Jr, DeVico AL, Lewis GK, Hone DM.

Vaccine. 2001 Nov 12;20(3-4):623-9.

PMID:
11672930
10.

Suppression of T-cell responsiveness by inducible cAMP early repressor (ICER).

Bodor J, Feigenbaum L, Bodorova J, Bare C, Reitz MS Jr, Gress RE.

J Leukoc Biol. 2001 Jun;69(6):1053-9.

PMID:
11404394
11.

HIV-1 protease inhibitor ritonavir modulates susceptibility to apoptosis of uninfected T cells.

Weichold FF, Bryant JL, Pati S, Barabitskaya O, Gallo RC, Reitz MS Jr.

J Hum Virol. 1999 Sep-Oct;2(5):261-9.

PMID:
10551732
12.

Recombinant IFN-alpha (2b) increases the expression of apoptosis receptor CD95 and chemokine receptors CCR1 and CCR3 in monocytoid cells.

Zella D, Barabitskaja O, Casareto L, Romerio F, Secchiero P, Reitz MS Jr, Gallo RC, Weichold FF.

J Immunol. 1999 Sep 15;163(6):3169-75.

13.

Perspective on Kaposi's sarcoma: facts, concepts, and conjectures.

Reitz MS Jr, Nerurkar LS, Gallo RC.

J Natl Cancer Inst. 1999 Sep 1;91(17):1453-8. Review. No abstract available.

PMID:
10469745
15.

Progressive and persistent downregulation of surface CXCR4 in CD4(+) T cells infected with human herpesvirus 7.

Secchiero P, Zella D, Barabitskaja O, Reitz MS, Capitani S, Gallo RC, Zauli G.

Blood. 1998 Dec 15;92(12):4521-8.

16.

CD4 promoter transactivation by human herpesvirus 6.

Flamand L, Romerio F, Reitz MS, Gallo RC.

J Virol. 1998 Nov;72(11):8797-805.

17.

Novel organizational features, captured cellular genes, and strain variability within the genome of KSHV/HHV8.

Nicholas J, Zong JC, Alcendor DJ, Ciufo DM, Poole LJ, Sarisky RT, Chiou CJ, Zhang X, Wan X, Guo HG, Reitz MS, Hayward GS.

J Natl Cancer Inst Monogr. 1998;(23):79-88.

PMID:
9709308
18.

A novel sensitive assay to define immune status using short-term peripheral blood derived cell culture and dual-color flow cytometry.

Zella D, Riva A, Weichold FF, Reitz MS Jr, Gerna G.

Immunol Lett. 1998 May;62(1):45-9.

PMID:
9672147
19.

Interferon-gamma increases expression of chemokine receptors CCR1, CCR3, and CCR5, but not CXCR4 in monocytoid U937 cells.

Zella D, Barabitskaja O, Burns JM, Romerio F, Dunn DE, Revello MG, Gerna G, Reitz MS Jr, Gallo RC, Weichold FF.

Blood. 1998 Jun 15;91(12):4444-50.

20.

Inhibition of HIV-1 replication by combined expression of gag dominant negative mutant and a human ribonuclease in a tightly controlled HIV-1 inducible vector.

Cara A, Rybak SM, Newton DL, Crowley R, Rottschafer SE, Reitz MS Jr, Gusella GL.

Gene Ther. 1998 Jan;5(1):65-75.

21.

Syncytium formation induced by human immunodeficiency virus type 1 isolates correlates with affinity for CD4.

Watkins BA, Crowley R, Davis AE, Louie AT, Reitz MS Jr.

J Gen Virol. 1997 Oct;78 ( Pt 10):2513-22.

PMID:
9349472
22.

New insight on the role of extrachromosomal retroviral DNA.

Cara A, Reitz MS Jr.

Leukemia. 1997 Sep;11(9):1395-9. Review.

PMID:
9305590
23.

Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization.

Lubeck MD, Natuk R, Myagkikh M, Kalyan N, Aldrich K, Sinangil F, Alipanah S, Murthy SC, Chanda PK, Nigida SM Jr, Markham PD, Zolla-Pazner S, Steimer K, Wade M, Reitz MS Jr, Arthur LO, Mizutani S, Davis A, Hung PP, Gallo RC, Eichberg J, Robert-Guroff M.

Nat Med. 1997 Jun;3(6):651-8.

PMID:
9176492
24.

Role of the extracellular domain of human herpesvirus 7 glycoprotein B in virus binding to cell surface heparan sulfate proteoglycans.

Secchiero P, Sun D, De Vico AL, Crowley RW, Reitz MS Jr, Zauli G, Lusso P, Gallo RC.

J Virol. 1997 Jun;71(6):4571-80.

25.

Chronic dietary L-arginine prevents endothelial dysfunction secondary to environmental tobacco smoke in normocholesterolemic rabbits.

Hutchison SJ, Reitz MS, Sudhir K, Sievers RE, Zhu BQ, Sun YP, Chou TM, Deedwania PC, Chatterjee K, Glantz SA, Parmley WW.

Hypertension. 1997 May;29(5):1186-91.

PMID:
9149685
26.

Humanization of an antibody recognizing a breast cancer specific epitope by CDR-grafting.

Fiorentini S, Matczak E, Gallo RC, Reitz MS, Keydar I, Watkins BA.

Immunotechnology. 1997 Mar;3(1):45-59.

PMID:
9154467
27.

Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6.

Nicholas J, Ruvolo VR, Burns WH, Sandford G, Wan X, Ciufo D, Hendrickson SB, Guo HG, Hayward GS, Reitz MS.

Nat Med. 1997 Mar;3(3):287-92.

PMID:
9055855
30.

Characterization of a chemokine receptor-related gene in human herpesvirus 8 and its expression in Kaposi's sarcoma.

Guo HG, Browning P, Nicholas J, Hayward GS, Tschachler E, Jiang YW, Sadowska M, Raffeld M, Colombini S, Gallo RC, Reitz MS Jr.

Virology. 1997 Feb 17;228(2):371-8.

31.

A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak.

Cheng EH, Nicholas J, Bellows DS, Hayward GS, Guo HG, Reitz MS, Hardwick JM.

Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):690-4.

32.

Identification of envelope glycoproteins H and B homologues of human herpesvirus 7.

Secchiero P, Berneman ZN, Sun D, Nicholas J, Reitz MS Jr.

Intervirology. 1997;40(1):22-32.

PMID:
9268767
33.
34.

Expression of CD26 does not correlate with the replication of macrophage-tropic strains of HIV-1 in T-cell lines.

Watkins BA, Crowley RW, Davis AE, Louie AT, Reitz MS Jr.

Virology. 1996 Oct 1;224(1):276-80.

35.

HIV-1 protein expression from synthetic circles of DNA mimicking the extrachromosomal forms of viral DNA.

Cara A, Cereseto A, Lori F, Reitz MS Jr.

J Biol Chem. 1996 Mar 8;271(10):5393-7.

36.

Evidence for distinct contributions of heavy and light chains to restriction of antibody recognition of the HIV-1 principal neutralization determinant.

Watkins BA, Davis AE, Fiorentini S, di Marzo Veronese F, Reitz MS Jr.

J Immunol. 1996 Feb 15;156(4):1676-83.

PMID:
8568275
37.

Using PCR for rapid site-specific mutagenesis in large plasmids.

Watkins BA, Reitz MS Jr.

Methods Mol Biol. 1996;57:217-27. Review. No abstract available.

PMID:
8850008
38.

Identification of human telomeric repeat motifs at the genome termini of human herpesvirus 7: structural analysis and heterogeneity.

Secchiero P, Nicholas J, Deng H, Xiaopeng T, van Loon N, Ruvolo VR, Berneman ZN, Reitz MS Jr, Dewhurst S.

J Virol. 1995 Dec;69(12):8041-5.

39.

V-region and class specific RT-PCR amplification of human immunoglobulin heavy and light chain genes from B-cell lines.

Watkins BA, Davis AE, Fiorentini S, Reitz MS Jr.

Scand J Immunol. 1995 Oct;42(4):442-8.

PMID:
7569777
40.

Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma.

Lunardi-Iskandar Y, Gill P, Lam VH, Zeman RA, Michaels F, Mann DL, Reitz MS Jr, Kaplan M, Berneman ZN, Carter D, et al.

J Natl Cancer Inst. 1995 Jul 5;87(13):974-81.

PMID:
7629884
41.

Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro.

Maciejewski JP, Weichold FF, Young NS, Cara A, Zella D, Reitz MS Jr, Gallo RC.

Nat Med. 1995 Jul;1(7):667-73.

PMID:
7585149
42.

Antisense phosphorothioate oligodeoxynucleotides alter HIV type 1 replication in cultured human macrophages and peripheral blood mononuclear cells.

Weichold FF, Lisziewicz J, Zeman RA, Nerurkar LS, Agrawal S, Reitz MS Jr, Gallo RC.

AIDS Res Hum Retroviruses. 1995 Jul;11(7):863-7.

PMID:
7546914
43.
46.

Multiple determinants for growth of human immunodeficiency virus type 1 in monocyte-macrophages.

Malykh A, Reitz MS Jr, Louie A, Hall L, Lori F.

Virology. 1995 Jan 10;206(1):646-50.

47.

Subgroup G HIV type 1 isolates from Nigeria.

Abimiku AG, Stern TL, Zwandor A, Markham PD, Calef C, Kyari S, Saxinger WC, Gallo RC, Robert-Guroff M, Reitz MS.

AIDS Res Hum Retroviruses. 1994 Nov;10(11):1581-3.

PMID:
7888214
48.

Viral variability and serum antibody response in a laboratory worker infected with HIV type 1 (HTLV type IIIB).

Reitz MS Jr, Hall L, Robert-Guroff M, Lautenberger J, Hahn BM, Shaw GM, Kong LI, Weiss SH, Waters D, Gallo RC, et al.

AIDS Res Hum Retroviruses. 1994 Sep;10(9):1143-55.

PMID:
7826699
49.

Phylogenesis and genetic complexity of the nonhuman primate retroviridae.

Franchini G, Reitz MS Jr.

AIDS Res Hum Retroviruses. 1994 Sep;10(9):1047-60. Review.

PMID:
7826692
50.

Alteration of V3 loop context within the envelope of human immunodeficiency virus type 1 enhances neutralization.

Robert-Guroff M, Louie A, Myagkikh M, Michaels F, Kieny MP, White-Scharf ME, Potts B, Grogg D, Reitz MS Jr.

J Virol. 1994 Jun;68(6):3459-66.

Supplemental Content

Loading ...
Support Center